| Republic of Korea | Thailand | Turkey | |
| Male Check-up | from AUD $1,300 | from AUD $240 | from AUD $720 |
No hidden fees – just official clinic prices. Pay at the clinic for Male Check-up upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Male Check-up and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Male Check-up journey.
Dr. Lee Chunyong is a urologist with a PhD in Medicine from Hanyang University College of Medicine. His clinical focus includes kidney and urinary stones (ESWL), prostate diseases (BPH, prostate cancer, prostatitis), sexual dysfunction, vasectomy, cystitis, urinary incontinence, and voiding dysfunction.
He has served as Director of Hanyang University Hospital. He was Chairman and Chief Professor of the Department of Urology at Hanyang University College of Medicine. He served as President and later Honorary President of the Korean Endourological Society. He was also a Board Member of the Société Internationale d'Urologie.
His international roles include Visiting Fellow at UCLA and Visiting Professor at the University of Tübingen. He was featured twice on EBS “Best Doctors,” covering prostatic diseases and kidney and urinary stones.
Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.
MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.
Dr. Song Hwayeong is a gastroenterologist. Areas of focus include gastrointestinal cancers (stomach and esophageal) and advanced endoscopy (gastroscopy, colonoscopy, ESD, and polypectomy). Dr. Song also treats digestive and liver diseases, including GERD, gastritis, hepatitis, H. pylori infection, and liver disease.
Dr. Song completed a fellowship in Gastroenterology at Inje University Ilsan Paik Hospital. Dr. Song has served as Clinical Professor at Inje, Gachon, and Inha University Colleges of Medicine. Dr. Song is Director of the Gastroenterology Center at Naeun Hospital.
Accreditations: full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, and the Korean Gastroenterology Association. Doping Committee Member, WKBL.
Selected papers: cryptogenic hepatocellular carcinoma; primary biliary cirrhosis with overlap syndromes; therapy for lamivudine-resistant chronic hepatitis B; and clevudine in HBV-related cirrhosis.